ALB and colorectal carcinoma: Therefore, we aimed to retrospectively investigate the association between baseline Alb levels and treatment outcomes in patients with metastatic CRC receiving FTD/TPI plus BEV, with the aim of determining whether Alb may serve as a predictive factor for its therapeutic efficacy.